Real-World Visual and Neovascularisation Outcomes from anti-VEGF in Central Retinal Vein Occlusion

Volume: 28, Issue: 1, Pages: 70 - 76
Published: Jul 12, 2020
Abstract
Purpose Central retinal vein occlusion (CRVO) can be complicated by macular oedema, requiring intravitreal injection (IVI) of anti-vascular endothelial growth factor (VEGF). CRVO can cause neovascularisation, potentially causing persistent pain if not identified early. Whilst clinical trial data describe visual and anti-neovascular benefit from anti-VEGF there are limited real-world data.Methods A retrospective cohort study of a consecutive...
Paper Details
Title
Real-World Visual and Neovascularisation Outcomes from anti-VEGF in Central Retinal Vein Occlusion
Published Date
Jul 12, 2020
Volume
28
Issue
1
Pages
70 - 76
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.